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Premalignant conditions of larynx encompass a variety of lesions that have the 
potential to evolve into malignant changes. The dysplastic premalignant epithelial 
changes of larynx have significantly increased Risk of developing in cancer than 
the hyperplastic stage of epithelial changes and this transformation significantly 
depends on the grade of dysplasia. Therefore, early diagnosis & prompt treat-
ment should thus prevent the development of invasive carcinoma requiring more 
debilitating surgical resection. The histopathological examination is diagnostic & 
the evolution of advanced laryngoscopic surgical procedures including CO2 laser 
and newer treatment methods such as photodynamic therapy has shown promising 
results in their management.
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1. Introduction
The location of larynx is quiet unique that is it lies at the crossroads of air and 
food passages often referred to as part of the upper aerodigestive tract. It is also 
known as the organ of phonation, owing to its anatomical evolution & ability to 
produce voice. Indeed, from a physiologic point of view, it is essentially a valve 
or sphincter with a triple function: that of an open valve in respiration; that of a 
partially closed valve whose orifice can be modulated in phonation; that of a closed 
valve, protecting the trachea and bronchial tree during deglutition [1].
The larynx commences at the laryngeal inlet, (consisting of epiglottis anteri-
orly, aryepiglottic folds on either sides and interarytenoid fold posteriorly) and 
extends to the inferior border of cricoid cartilage, lying opposite the 3rd to 6th 
cervical vertebrae in adults and is somewhat higher in children. Structurally, it can 
be divided into three subsites, namely, the supraglottis, glottis and the subglottis 
by true and false vocal folds.
There are certain areas of larynx which are difficult to visualize through routine 
outpatient procedures like indirect laryngoscopy and these areas are of great clinical 
importance since many a times tumors tend to involve these subsites and are missed 
due to their anatomical location. Hence these areas require a special mention when 
discussing the anatomy.
Anterior commissure (anterior convergence of vocal folds and its insertion 
into the laminae of thyroid cartilage) is difficult to visualize through indirect 
laryngoscopy, it is located at the anterior junction of the two vocal folds, many a 
times a residual tumor is left behind during the surgical management; and if not 
managed properly, causes notable post-op morbidity. Between the two arytenoid 
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cartilages is present the posterior commissure. The vocal folds extend anteriorly to 
form a concentration of collagen fibres, known as anterior commissure tendon or 
Broyle’s ligament which is attached to the deep layer of lamina propria and the inner 
perichondrium of the thyroid cartilage. Broyle’s ligament, being devoid of glands, 
is resistant to the spread of tumors and hence acts as an effective safety barrier for 
further spread of malignancy. On the other hand, the mucosa of the glottis, lying 
superior and inferior to this ligament, is thrown back on the bare areas of thyroid 
cartilage, which can gave way to malignancies to invade the thyroid cartilage.
Histologically, two types of mucosal linings can be seen in larynx. Most of it is 
lined by pseudostratified ciliated columnar (respiratory) epithelium, except the 
vocal folds, the posterior glottis, a part of aryepiglottic folds and half of posterior 
surface of epiglottis, which are lined by non-keratinizing stratified squamous 
epithelium. The transition between the two epithelia, marked by the inferior arcu-
ate line (present on the upper surface of vocal folds), is a common site for squamous 
cell carcinoma in larynx. The mucous glands, though freely dispersed throughout 
the mucosa of the larynx, are exceptionally numerous on the posterior surface of 
epiglottis and in the saccule. The mucus from the glands in the saccule are respon-
sible for the lubrication of the vocal folds [2].
The malignancy was recognized long back in ancient times but the concept of 
premalignancy was not introduced till the end of 19th century. The term prema-
lignant/precancer was introduced by Dubreuilh in 1896 for skin lesion and during 
the same era Durant described the first documented cases of laryngeal leukoplakia 
as “white cicatrices” adjacent to a malignant laryngeal lesion [3]. Later after almost 
4 decades Jackson in 1923 conceptulized premalignancy of larynx as similar to a 
“large no. of citizens leaving their regular daily routine & mobilizing preparatory to 
invasion” [4].
Laryngeal cancer is the most common cause of head neck cancer in United States 
of America & is responsible for thousands of death each year [5]. The best chance 
of curing any cancer is via its early detection and eradication as morbidity and 
mortality are proportionately related to stage. Thus, appropriate management of 
precancerous laryngeal lesions in those patients fortunate enough to present at this 
stage is obviously vital.
The premalignant lesions of larynx are the identifiable local features that with 
time has a tendency to transform into invasive carcinoma. This change in the local 
sign occurs basically due to changes in the laryngeal cell that may lead to dysplastic 
or hyperplastic epithelial changes. WHO (World Health Organization) has defined 
premalignant lesions of larynx as morphological alterations of the mucosa caused by 
chronic local irritative factors as referable to local expression of generalized illness, 
presenting a higher probability of degeneration into the carcinoma with respect to 
surrounding mucosa. Moreover, WHO has classified these lesions on the basis of 
hyperplasia & various degree of dysplastic changes into simple squamous cell hyper-
plasia, mild dysplasia, moderate dysplasia, severe dysplasia & carcinoma in situ [6].
The epidemiology of premalignant lesions, reveals a scarce data. However, it 
is known that these lesions are more prevalent in males and are frequently seen in 
patients above 50 years of age.
A wide array of conditions have been implicated in the development & rapid 
transformation of premalignant lesions into an invasive cancer, including long-term 
tobacco exposure and alcohol abuse, various occupational professions related to the 
textile industry, chemical industries dealing with wood processing. A small propor-
tion of carcinomas appears to be related to transcriptionally active human papil-
lomavirus infection. So these factors basically changes the morphology of the glottis 
epithelial cells into hyperplastic & dysplastic changes. To understand this we must 
know the normal epithelial spread of larynx (Table 1) (Figures 1 and 2).
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Although we are concerned about premalignant lesion only but this is impor-
tant to understand the possible histological variety of malignant neoplasms that 
may arise in the larynx (Table 2) reflecting the different tissues from which they 
Nonkeratinized stratified 
squamous epithelium
Pseudostratified ciliated columnar 
epithelium with globet cells
Seromucinous glands
Anterior epiglottic surface Ventricular folds Posterior epiglottic 
surface
Upper half of the posterior 
epiglottic surface
Ventricle False vocal cords
Superior margin of A-E folds Saccule Ventricle
Vocal cords Subglottic region Saccule & subglottis
Table 1. 
Normal histology of larynx.
Figure 1. 
Histological view of larynx (Nonkeratinized stratified squamous epithelium).
Figure 2. 
Histological view of larynx (Pseudostratified ciliated columnar epithelium).
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originate. The vast majority, however, are squamous carcinomas (up to 95%) and 
predominantly arise on the true vocal folds. All other histological subtypes will 
necessarily develop via a premalignant phase, but due to the paucity of such cases 
in the literature they have not been studied and characterized to the same extent as 
premalignant squamous carcinomatous lesions [7].
So it is the normal histological pattern which undergoes these various changes at 
the cellular & genetic level under the influence of various factors as already men-
tioned above, thus changes into a dysplastic or hyperplastic variation may occur, 
making it vulnerable to transform into a cancerous lesion.
The macroscopic changes of the lesions have no appearance & hence in clinical 
practice are commonly referred as: leukoplakia, erythroplakia, erythroleukoplakia, 
keratosis and chronic laryngitis although there is no consensus on this issue. The 
current laryngeal investigation systems for obtaining the high quality & resolution 
images so as to reveal the detailed morphology of glottis structures is one of the 
main task in laryngeal imaging & helps in diagnosis. These includes:




• Narrow band imaging (NBI)
• Ultrasound
• Computed axial tomography (CAT)/Magnetic resonance imaging (MRI)
So the appearance of lesion with these mentioned investigation system is no 
doubt of great help in diagnosis & prognosis of lesion but histopathological appear-
ance is always diagnostic.
2. Etiology
The risk factors for pre malignant tumors of larynx are primarily similar to those 
of laryngeal carcinoma. These risk factors may cause conversion of a dysplastic 























2.  Small cell
Table 2. 
Histological Subtypes of Laryngeal Malignancies and their variants.
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neoplasia is a preventable disease in the vast majority of cases, which points out the 
role of various environmental and social factors. The most commonly and strongly 
implicated factor remains smoking. Burning cigarettes release tar that contains 
polycyclic aromatic hydrocarbons which have been proven to be carcinogenic and 
act by damaging the nucleic acids in the cells. Similarly, alcohol consumption may 
be an independent risk factor & in such people, supraglottic carcinoma is frequently 
seen. Though alcohol is directly implicated in carcinogenesis, it may be associated 
with other co morbidities and deficiencies as in malnutrition or vitamin deficien-
cies. When alcohol consumption is combined with smoking, the risk of neoplasia 
multiplies.
Other known etiological factor for oropharyngeal carcinoma includes the 
Human Papilloma Virus or the HPV; the serotypes strongly associated with oropha-
ryngeal carcinoma are 16 and 18 (as seen in carcinoma cervix) [8].
In most HPV positive laryngeal carcinomas, serotype 16 is frequently isolated, 
while in recurrent respiratory papillomatosis, serotypes 6 and 11 are commonly 
isolated.
Recurrent respiratory papillomatosis does not usually turn into squamous carci-
noma, owing to different pathogenesis, however this transformation may be seen in 
patients who have a history of exposure to radiation.
The epidemiological studies have shown that the prevalence of HPV in patients 
of laryngeal carcinoma varies greatly i.e., between 0% to 58% (grossly around 
25%), depending upon the investigations and the population [9]. Lately, studies 
have shown that HPV and carcinoma larynx are not strongly co related. On the 
other hand, it has been seen that HPV can be present in people with otherwise 
histologically normal epithelium of larynx and with no signs or symptoms [10].
The association of GERD (Gastro Esophageal Reflux Disorder) with laryngeal 
malignancy has been explored by many researchers. Olson in 1983 was the pioneer 
to study the role of chronic laryngopharyngeal reflux (LPR) in laryngeal carcinoma 
[11]. He found a significant relationship between these two pathologies, where the 
incidence of laryngeal carcinoma was higher in patients suffering from LPR [7]. 
On the contrary Chen et al. found no association between GERD and laryngeal 
neoplasia [12].
Many other environmental factors have been known to increase the risk of 
laryngeal malignancy such as industrial pollutants like asbestos, malnutrition, 
lower socioeconomic status etc. [13]. Exposure to radiation for managing other neck 
tumors like thyroid cancer can also predispose to laryngeal malignancies [14].
Even the role of genetic factors have been implicated to increase the sus-
ceptibility of an individual to develop laryngeal neoplasia such as enzymatic 
polymorphisms in elimination and detoxification of alcohol and smoke produced 
carcinogens [15].
3. Molecular genetics
The concept of field cancerization was introduced by Slaughter et al in a study 
of oral cancer [16]. He found that there occurred histopathological abnormalities in 
the epithelium surrounding the invasive cancer and the abnormalities ranged from 
keratosis, dysplasia and hyperkeratosis, epithelial hyperplasia etc. With this concept 
many researchers tried to study the genetics around the tumor site and premalig-
nant conditions to predict their clinical outcome. In many tumor types, including 
HNSCC (Head and Neck squamous cell carcinoma), p53 inactivation apparently 
occurs in the transition from the preinvasive to the invasive state [17]. A second 
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17p13 locus may be altered earlier in progression. Existence of an alternate gene in 
this region has been implied in the genetic progression of brain and breast cancer 
[18, 19]. In a study by Califano et al the analysis of premalignant lesions was carried 
out a genetic level, they concluded that early genetic study of a premalignant lesion 
could aid and influence our treatment strategies from a conservative to a more 
aggressive one according to the genetic events detected [20].
4. Classification
Various classification of premalignant laryngeal lesions have been given by various 
authors, still it continues to be a controversial topic of laryngeal pathology for decades 
now, considering the classification, histological diagnosis and the treatment aspect as 
well. For clinical management of these lesions system based on the evaluation of the 
grade of hyperplasia and/or dysplasia of epithelium have been established (Table 2).
According to Hellquist et al [21] a distinction can be made between various lesions:
• Grade I lesions, presenting hyperplasia and/or keratosis with or without mild 
dysplasia where stratification is preserved and superficial cellular layers show 
cytoplasmic differentiation.
The cellular and architectural atypia occur in the lower third part with nuclear 
crowding, cellular and nuclear pleomorphism with increased nuclear/cytoplas-
mic ratio.
• Grade II lesions characterized by moderate dysplasia. Histologic changes are 
similar to grade I but abnormalities extend up to two-third of the thickness of 
the epithelium, hence the differentiation & stratification is seen in superficial 
layers with numerous mitotic features.
• Grade III lesions, in which dysplasia is severe or of such type as to configure 
carcinoma in situ. Here, non-stratified & undifferentiated cells occupy from 
more than two-third up to the full thickness of the epithelium in majority of 
the cases there is no keratinization. Nuclear pleomorphism is seen with-bizarre 
large nuclei & the lesion is always contained by the basal lamina.
This grading is based on the classification proposed by the Kleinsasser in 19631 
and later, by Delemarre, distinguishing a first class characterized by simple squa-
mous cell hyperplasia, a second class represented by squamous cell hyperplasia with 
atypia and third class represented by carcinoma in situ.
The modified Ljubljana [22, 23] classification, the modification done by a work-
ing group of European society of pathology in November 1997 in London, United 
Kingdom (UK) devised the classification to cater to specific clinical and histological 
laryngeal problems, as it does not follow the three grade criteria, so was divided it 
into four grades as follows:
1. Simple hyperplasia (SH) is benign group.
2. Abnormal hyperplasia (AbH) is benign group.
3. Atypical hyperplasia (AtH) is potentially malignant.
4. Carcinoma in situ is malignant.
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The term dysplasia was accepted in laryngeal pathology first after the Toronto 
Centennial Conference on Laryngeal Cancer in 1974, almost after 11 years of 
proposed Kleinsasser classification. Several terms such as squamous intraepithelial 
neoplasia (SIN) and laryngeal intraepithelial neoplasia (LIN) were introduced. The 
term squamous intraepithelial neoplasia (SIN) was used for laryngeal precursor 
lesions by Friedmann and Osborn in 1976, and 10 years later Crissman and Fu opted 
for intraepithelial neoplasia of the larynx [24]. In addition, Friedmann and Ferlito 
used laryngeal intraepithelial neoplasia (LIN) [25]. An attempt to reconcile differ-
ent schemes showed:
1. LIN I is regarded the equivalent of mild dysplasia
2. LIN II of moderate dysplasia and
3. LIN III of severe dysplasia and carcinoma in situ.
After that many editions of the World Health Organization (WHO) classifica-
tion have been proposed & all such terms like as squamous intraepithelial neoplasia 
(SIN) and laryngeal intraepithelial neoplasia (LIN) were used but are now being 
abandoned and replaced by squamous intraepithelial lesions (SIL) [26, 27]. The 
essential update in the four editions of WHO was the attempt to induce a simplifica-
tion from a four- to a two-tier system. The current WHO classification (2017) thus 
recommends the use of a two-tier system with reasonably clear histopathological 
criteria for the two groups:
1. Low-grade and
2. High-grade dysplasia.
Although the disadvantages like inter observer variability apart, subjectivities 
and uncertainties still remains but to a lesser degree.
Hence, it is very difficult to predict accurately which lesions will progress into 
invasive malignancy based only on clinical appearance. The diagnosis, treatment 
and prognosis of these lesions depend almost entirely on their histological abnor-
malities. In Table 3 we have compared the different classifications given by differ-
ent authors.
4.1 Clinical features
The most common presentation of patients harboring premalignant lesions is 
dysphonia which can be progressive or fluctuating. Rarely patients may even pres-
ent with breathing difficulty or foreign body sensation throat.
The diagnosis is made by doing a flexible endoscopy. These lesions either 
appear as white keratotic patches, single, multiple or confluent (Figures 3-5). 
They are also seen as erythroplakia (red), mixed leucoerythroplakic (speckled) 
patches.
In general clinical appearance has shown to have poor correlation with the 
state of underlying epithelium [28, 29]. Still a few authors have found higher 
chances of malignancy and dysplasia with certain types of lesions. Following 
features in decreasing order of importance, ulceration, erythroplasia, surface 
granularity, increased keratin thickness (verrucous appearance), increased size, 
recurrence after excisional biopsies and long duration have all been associated 
with carcinoma [30].
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Figure 3. 
Single keratotic lesion seen involving the left true vocal fold.
4.2 Management
The management of premalignant lesions is challenging for a clinician as it poses 
a diagnostic challenge and also because it requires close monitoring and follow up 
due to underlying risk of malignancy.
The laryngeal cancer represents about 1–2% of all malignant tumors. In 90% 
of cases carcinomas develop from precancerous epithelial lesions [31]. Prompt 
treatment after an early diagnosis is capable to prevent the development of an 
invasive neoplasm and the consequent recourse to more invasive laryngeal sur-
gery [32, 33]. Lack of valid protocol or guidelines to manage such precancerous 























































Various classifications of laryngeal precancerous conditions.
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The dilemma in managing premalignant conditions lies in whether to man-
age it conservatively with close follow up or to do a biopsy. The invasiveness of 
the lesion and the prediction whether a lesion has a malignant potential cannot 
be assessed by clinical examination. Even various investigation modalities like 
Figure 5. 
Endoscopic image depicting a single confluent lesion involving the right Vocal Fold.
Figure 4. 
Multiple Keratotic Lesion involving the bilateral arytenoids.
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endoscopy, stroboscopy fail to analyse the invasiveness of lesion. Newer tech-
niques such as contact endoscopy using highly magnified images (up to 150 X) 
using a rigid endoscope which is placed in direct contact with vocal fold epithe-
lium and staining is done using 1% methylene blue dye. Though it has been found 
to have a high sensitivity and specificity still its limitation to unable to detect the 
dysplasia in deeper layers and the learning curve associated with it and requir-
ing an expertise of a pathologist has made its application limited in the field of 
otorhinolaryngology [28, 32, 34].
In an attempt to formulate a plan a meeting of UK otolaryngologists and 
pathologists involved in the care of Head and Neck cancer was held and guidance 
in relation to premalignant conditions was issued [35]. In case of single  
(Figure 3) and multiple foci (Figure 4) they should be completely excised to all 
visible margins, if possible and in the presence of widespread, confluent leuko-
plakia (Figure 5), histopathological mapping of the lesion with multiple biopsies 
should be initially performed, followed by staged resection, if feasible. Once 
sending the biopsy specimen proper labelling and anatomical orientation should 
be presented on a template to the pathologist with photo documentation prior to 
histological analysis.
The patient’s general condition and fitness for surgery, physiological age, 
comorbidity and the presence of other risk factors also play a vital role in planning a 
surgical procedure. The most essential step to be taken before planning the surgi-
cal procedure is a detailed and vivid discussion with the patient to inform him/her 
about the potential risks of hoarseness and change in voice quality postoperatively 
and about the possibility of recurrence.
4.3 Surgical treatment
The surgical procedure options are in the form of cold steel or carbon dioxide 
(CO2) laser resection. Both are taken up via an endoscopic approach. If laser excision 
is planned, CO2 laser is a preferred laser type. The use of the laser for ablation is to be 
discouraged, because no specimen is provided for diagnosis and it may be Associated 
with a possible higher risk of damage and impact on voice production. Hence, strip-
ping of the cord is also not recommended due to the poor quality voice issues.
There are a few vital points which should be borne in mind while dissecting 
these lesions and they are as following: A proper plane of dissection should be 
achieved and the vocal ligament should be preserved so as to attain a good postop-
erative voice quality. An overzealous dissection can lead to postoperative scarring 
and poor voice outcomes. In such cases excision biopsy is performed with special 
care so as to preserve the deeper layers of vocal cords and the surrounding nor-
mal mucosa.
In case of anterior commissure lesions there is a risk of recurrence and their 
progression to cancer is reported in literature so adequate clearance and  
regular follow up is required in case the disease is progressing to anterior  
commissure.
4.4 Radiotherapy
Role of radiotherapy in premalignant conditions is only reserved for those 
patients, in whom the surgical intervention is contraindicated due to morbidity. 
Many studies have shown that radiation therapy to be ineffective in preventing 
the progression of dysplastic lesions to carcinoma; in fact, it may even precipitate 
malignant degeneration [30]. Therefore, the application of radiation therapy should 
be reserved for invasive carcinoma only.
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4.5 Follow up
The follow up of such patients is the most vital part of their management since 
there is always a risk of recurrence and malignant transformation. In the literature 
no fixed protocol has been designed for the follow up plan of premalignant lesions 
but it has been noted that malignant transformation rate is higher with moderate 
to severe dysplasia as compared to mild dysplasia [15]. To simplify things we follow 
a self-designed protocol according to which we divide the patients into two groups 
that is the high risk and low risk group. Now patients in high risk group are those 
who have moderate, severe dysplasia and carcinoma in situ (according to WHO 
classification) and patients even with mild dysplasia but who are cigarette smok-
ers, heavy alcohol consumers are included in this group. In high risk we follow the 
same protocol as T1 carcinoma that is for initial 2 years every month follow up, 2 
monthly in the second year, 3 monthly in the third year and 6 monthly in fourth 
and fifth year.
In cases of low risk group the follow up plan was to do a regular monthly check 
up for at least 6 months. Following that clear instructions to the patient to revert 
back, if there is change in voice and on appearance of any suspicious symptoms.
4.6 Other treatment options
Photodynamic Therapy (PDT) is a minimally invasive treatment that involves 
the activation by light of a drug (photosensitizer) that generates cytotoxic reactive 
oxygen species. This therapy has been specially studied in cases of premalignant 
laryngeal lesions. A clinical trial was conducted in 2014 using a compound named 
3-(1’-hexyloxyethyl) pyropheophorbide (HPPH) mediated photodynamic therapy 
[36]. The results of this phase I b trials were very promising with a fewer com-
plications rate. Though this clinical trial is still underway and hence awaiting its 
approval. Its use in oral cancer lesions, especially for the recurrent ones has been 
established by many authors [37].
5. Conclusion
Early diagnosis, timely management and a regular follow of patients harboring 
premalignant lesions can prevent its progression to full blown laryngeal carcinoma. 
The newer treatment modalities in the form of photodynamic therapy though are in 
their initial phase of testing but they do show a potential in future management of 
such lesions.
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